Mercaptopurine
Mercaptopurine is an oral suspension prescription drug that inhibits nucleic acid synthesis, used to treat certain cancers like leukemia. It comes in a 20 mg/mL strength, manufactured by Hikma Pharmaceuticals USA Inc. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Mercaptopurine is an oral suspension prescription drug that inhibits nucleic acid synthesis, used to treat certain cancers like leukemia. It comes in a 20 mg/mL strength, manufactured by Hikma Pharmaceuticals USA Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Mercaptopurine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Mercaptopurine — ANDA 205919 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205919"
}
]
|
| identifier | ANDA205919 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"fda",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Mercaptopurine |
